<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="id">6773</item><item key="factors"><item><item key="GSM87035"><item key="CELL TYPE SORTED">nTreg</item></item></item><item><item key="GSM87035"><item key="CELL TYPE SORTED">nTreg</item></item></item><item><item key="GSM870353"><item key="CELL TYPE SORTED">iTreg</item></item></item><item><item key="GSM870353"><item key="CELL TYPE SORTED">iTreg</item></item></item><item><item key="GSM870355"><item key="CELL TYPE SORTED">ex-iTreg</item></item></item><item><item key="GSM870355"><item key="CELL TYPE SORTED">ex-iTreg</item></item></item></item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">6</item><item key="summary_wrapped">Induced Treg (iTreg) cells are essential for tolerance and can be used therapeutically, yet their stability in vivo and mechanisms of...</item><item key="pubmed_id">23125413</item><item key="geo_gse_id">E-GEOD-35543</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">1</item><item key="sample_count">6</item><item key="tags"><item>cell</item><item>colitis</item><item>lymph</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">gene-expression-profiling-of-in-vitro-derived-indu</item><item key="geo_id_plat">E-GEOD-35543_A-AFFY-45</item><item key="name">Gene expression profiling of in vitro derived induced and natural FOXP3+ regulatory T cells and ex-iTreg cells in the mouse</item><item key="created">Nov.12, 2014</item><item key="summary">Induced Treg (iTreg) cells are essential for tolerance and can be used therapeutically, yet their stability in vivo and mechanisms of suppression are unresolved. Here, we used a treatment model of colitis to examine the role of autologous IL-10 in iTreg cell function.  Mice treated with IL-10+/+ iTreg cells in combination with IL-10&#8211;/&#8211; natural Treg (nTreg) cells survived and gained weight, even though iTreg cells were numerically disadvantaged and comprised just ~20% of all Treg cells in treated mice.   Notably, ~85% of the transferred iTreg cells lost Foxp3 expression (ex-iTreg) but retained a portion of the iTreg transcriptome which failed to limit their pathogenic potential. The TCR repertoires of iTreg and ex-iTreg cells exhibited almost no overlap, which indicates that the two populations are clonally unrelated and maintained by different selective pressures.  These data demonstrate a potent and critical role for iTreg cell produced IL-10 that can supplant the IL-10 produced by nTreg cells and compensate for the inherent instability of the iTreg population. BALB/c Rag1-/- mice were treated with 500,00 WT nTreg cells plus 500,000 WT in-vitro-derived iTreg cells.  After 125 days cells were sorted by flow cytometry from spleens and mesenteric lymph nodes from 14 treated mice.  EGFP+ Thy1.1+ iTreg cells, EGFP+ Thy1.1&#8211; nTreg cells, and EGFP&#8211;Thy1.1+ ex-iTreg cells were pooled  and used to generate total RNA for each iTreg, nTreg, and ex-iTreg array set, which was labeled and hybridized to Affymetrix 430 2.0 GeneChips in accordance to the manufacturer&#8217;s protocol. Two sets of arrays were performed, and the results were averaged. Both iTreg and nTreg array sets were compared to a) na&#239;ve CD4+EGFP&#8211; Tconv cells from Foxp3EGFP.  The subset of probe sets whose expression increased or decreased by twofold or more relative to Tconv cells as a common standard was identified and used for further analysis.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-35543</item><item key="species">mouse</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-35543/samples/</item></data></biogps>
